vs
Side-by-side financial comparison of Beta Bionics, Inc. (BBNX) and GREENE COUNTY BANCORP INC (GCBC). Click either name above to swap in a different company.
Beta Bionics, Inc. is the larger business by last-quarter revenue ($27.6M vs $22.2M, roughly 1.2× GREENE COUNTY BANCORP INC). GREENE COUNTY BANCORP INC runs the higher net margin — 46.3% vs -79.3%, a 125.6% gap on every dollar of revenue. On growth, Beta Bionics, Inc. posted the faster year-over-year revenue change (56.6% vs 23.8%).
Beta Bionics, Inc. is a medical technology company focused on developing and commercializing advanced automated diabetes management solutions. Its core product is the iLet Bionic Pancreas, a wearable device that automatically adjusts insulin and glucagon delivery for people with Type 1 and Type 2 diabetes, serving primarily the U.S. healthcare market with plans for global expansion.
Bank of Greene County is an American federally-chartered savings bank headquartered in Catskill, NY. The bank's branches are located in the Upstate New York counties of Greene, Columbia, Albany, Ulster, and Rensselaer.
BBNX vs GCBC — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $27.6M | $22.2M |
| Net Profit | $-21.9M | $10.3M |
| Gross Margin | 59.5% | — |
| Operating Margin | -47.4% | 52.0% |
| Net Margin | -79.3% | 46.3% |
| Revenue YoY | 56.6% | 23.8% |
| Net Profit YoY | 23.6% | 37.4% |
| EPS (diluted) | $-0.49 | $0.60 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $27.6M | — | ||
| Q4 25 | $32.1M | $22.2M | ||
| Q3 25 | $27.3M | $21.5M | ||
| Q2 25 | $23.2M | $20.5M | ||
| Q1 25 | $17.6M | $20.1M | ||
| Q4 24 | — | $17.9M | ||
| Q3 24 | — | $16.9M | ||
| Q2 24 | — | $16.6M |
| Q1 26 | $-21.9M | — | ||
| Q4 25 | $-13.5M | $10.3M | ||
| Q3 25 | $-14.2M | $8.9M | ||
| Q2 25 | $-16.9M | $9.3M | ||
| Q1 25 | $-28.7M | $8.1M | ||
| Q4 24 | — | $7.5M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $6.7M |
| Q1 26 | 59.5% | — | ||
| Q4 25 | 59.0% | — | ||
| Q3 25 | 55.5% | — | ||
| Q2 25 | 53.8% | — | ||
| Q1 25 | 50.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | -47.4% | — | ||
| Q4 25 | -50.2% | 52.0% | ||
| Q3 25 | -62.5% | 47.4% | ||
| Q2 25 | -85.5% | 53.5% | ||
| Q1 25 | -105.7% | 44.6% | ||
| Q4 24 | — | 45.0% | ||
| Q3 24 | — | 39.6% | ||
| Q2 24 | — | 41.2% |
| Q1 26 | -79.3% | — | ||
| Q4 25 | -41.9% | 46.3% | ||
| Q3 25 | -52.1% | 41.2% | ||
| Q2 25 | -72.6% | 45.6% | ||
| Q1 25 | -162.5% | 40.1% | ||
| Q4 24 | — | 41.7% | ||
| Q3 24 | — | 37.1% | ||
| Q2 24 | — | 40.6% |
| Q1 26 | $-0.49 | — | ||
| Q4 25 | $-0.16 | $0.60 | ||
| Q3 25 | $-0.33 | $0.52 | ||
| Q2 25 | $-0.39 | $0.55 | ||
| Q1 25 | $-0.93 | $0.47 | ||
| Q4 24 | — | $0.44 | ||
| Q3 24 | — | $0.37 | ||
| Q2 24 | — | $0.39 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $199.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $271.2M | $258.3M |
| Total Assets | $304.4M | $3.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $199.5M | — | ||
| Q4 25 | $219.1M | — | ||
| Q3 25 | $228.7M | — | ||
| Q2 25 | $249.7M | — | ||
| Q1 25 | $231.5M | $155.5M | ||
| Q4 24 | — | $166.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $190.4M |
| Q1 26 | $271.2M | — | ||
| Q4 25 | $287.6M | $258.3M | ||
| Q3 25 | $294.8M | $248.2M | ||
| Q2 25 | $301.6M | $238.8M | ||
| Q1 25 | $313.8M | $229.0M | ||
| Q4 24 | — | $218.4M | ||
| Q3 24 | — | $216.3M | ||
| Q2 24 | — | $206.0M |
| Q1 26 | $304.4M | — | ||
| Q4 25 | $328.7M | $3.1B | ||
| Q3 25 | $330.0M | $3.1B | ||
| Q2 25 | $330.0M | $3.0B | ||
| Q1 25 | $338.0M | $3.0B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | — | $2.9B | ||
| Q2 24 | — | $2.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $6.4M |
| Free Cash FlowOCF − Capex | — | $6.2M |
| FCF MarginFCF / Revenue | — | 28.0% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | 0.62× |
| TTM Free Cash FlowTrailing 4 quarters | — | $47.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-8.6M | $6.4M | ||
| Q3 25 | $-8.7M | $7.0M | ||
| Q2 25 | $-13.6M | $28.0M | ||
| Q1 25 | $-20.0M | $7.3M | ||
| Q4 24 | — | $5.3M | ||
| Q3 24 | — | $2.1M | ||
| Q2 24 | — | $24.9M |
| Q1 26 | — | — | ||
| Q4 25 | $-10.5M | $6.2M | ||
| Q3 25 | $-10.0M | $6.5M | ||
| Q2 25 | $-15.4M | $27.3M | ||
| Q1 25 | $-20.3M | $7.3M | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | — | $2.0M | ||
| Q2 24 | — | $23.4M |
| Q1 26 | — | — | ||
| Q4 25 | -32.8% | 28.0% | ||
| Q3 25 | -36.7% | 30.4% | ||
| Q2 25 | -66.2% | 133.3% | ||
| Q1 25 | -115.1% | 36.1% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 11.8% | ||
| Q2 24 | — | 141.2% |
| Q1 26 | — | — | ||
| Q4 25 | 5.9% | 0.9% | ||
| Q3 25 | 4.7% | 1.9% | ||
| Q2 25 | 7.7% | 3.4% | ||
| Q1 25 | 1.9% | 0.3% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 9.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.62× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 3.00× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 0.71× | ||
| Q3 24 | — | 0.34× | ||
| Q2 24 | — | 3.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
